New antibiotics for infections caused by resistant organisms

Supportive Care in Cancer

Volumn 9, Issue 1, 2001, Pages 8-10

  McKinnon, Peggy S ^a   Tam, V H ^a  

^a DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

Bacterial resistance; Enterococcus; Staphylococcus; Streptococcus

Indexed keywords

CEFEPIME; CEPHALOSPORIN DERIVATIVE; CETHROMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; EVERNIMICIN; EVERNINOMICIN; GATIFLOXACIN; GREPAFLOXACIN; KETOLIDE; LINEZOLID; MEROPENEM; METICILLIN; MOXIFLOXACIN; ORITAVANCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOGRAMIN; TELITHROMYCIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ENTEROCOCCUS; HUMAN; INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYALGIA; PHLEBITIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; FLUOROQUINOLONES; HUMANS; VIRGINIAMYCIN;

EID: 0035141132     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200000177     Document Type: Review

References (14)

1. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials
2. Nosocomial bloodstream infections in United States hospitals: A three-year analysis
3. Pharmacologic and bacteriologic properties of SCH-27899 (ziracin), an investigational antibiotic from the everninomicin family
4. Vancomycin resistant and vancomycin susceptible enterococcal bacteremia: Comparison of clinical features and outcomes
5. Treatment outcomes of vancomycin resistant E. faecium and vancomycin resistant E. faecalis compared to vancomycin susceptible strains
6. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia
7. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin resistant Enterococcus faecium
8. Vancomycin resistant enterocccal infections
9. Treatment of hospitalized patients with complicated gram-positive and skin structure infections: Two randomized, multicenter studies of quinupristin/dalfopristin, cefazolin, oxacillin, or vancomycin
10. Comparative in vitro activities and postanti biotic effects of the oxazolidinone compounds eperezolid and linezolid vs. vancomycin against S. aureus, coagulase-negative Staphylococci E. faecalis, E. faecium
11. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
12. Emergence of vancomycin resistance in Staphylococcus aureus
13. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?
14. Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence